List of Excipients in API telmisartan, amlodipine and indapamide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing telmisartan, amlodipine and indapamide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Azurity Pharmaceuticals Inc | WIDAPLIK | telmisartan, amlodipine and indapamide | 24338-001 | CROSCARMELLOSE SODIUM | 2028-06-05 |
| Azurity Pharmaceuticals Inc | WIDAPLIK | telmisartan, amlodipine and indapamide | 24338-001 | MAGNESIUM STEARATE | 2028-06-05 |
| Azurity Pharmaceuticals Inc | WIDAPLIK | telmisartan, amlodipine and indapamide | 24338-001 | MANNITOL | 2028-06-05 |
| Azurity Pharmaceuticals Inc | WIDAPLIK | telmisartan, amlodipine and indapamide | 24338-001 | MEGLUMINE | 2028-06-05 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for telmisartan, amlodipine and indapamide
Excipient focus: CROSCARMELLOSE SODIUM
telmisartan, amlodipine and indapamide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
telmisartan, amlodipine and indapamide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
telmisartan, amlodipine and indapamide drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEGLUMINE
telmisartan, amlodipine and indapamide drug variants containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing MEGLUMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
telmisartan, amlodipine and indapamide drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
telmisartan, amlodipine and indapamide drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
telmisartan, amlodipine and indapamide drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
telmisartan, amlodipine and indapamide drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Azurity Pharmaceuticals Inc | telmisartan, amlodipine and indapamide | 24338-001 |
| >Company | >Ingredient | >NDC |
telmisartan, amlodipine and indapamide drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch